Efficacy, safety, and patient-reported outcomes across young to older age groups of patients with HR+/HER2– advanced breast cancer treated with ribociclib plus endocrine therapy in the randomized MONALEESA-2, −3, and −7 trials
Titel:
Efficacy, safety, and patient-reported outcomes across young to older age groups of patients with HR+/HER2– advanced breast cancer treated with ribociclib plus endocrine therapy in the randomized MONALEESA-2, −3, and −7 trials
Auteur:
Hart, Lowell L. Im, Seock-Ah Tolaney, Sara M. Campone, Mario Pluard, Timothy Sousa, Berta Freyer, Gilles Decker, Thomas Kalinsky, Kevin Sopher, Gary Gao, Melissa Hu, Huilin Kuemmel, Sherko